Stock Track | MODERN CHI MED Plummets 6.13% Intraday After Reporting FY2025 Loss and 32% Revenue Decline

Stock Track03-31

MODERN CHI MED's stock plummeted 6.13% during intraday trading on Tuesday.

The sharp decline followed the company's release of its full-year 2025 financial results, which showed a significant deterioration in performance. Modern Chinese Medicine Group swung to a net loss of RMB13.56 million for the year ended December 31, 2025, reversing a profit of RMB9.67 million in 2024.

Revenue fell 32.2% to RMB145.17 million, which management attributed to the loss of certain distributors, the removal of key products from China's national medical-insurance list, and price reductions under volume-based procurement reforms. The gross margin compressed to 16.2% from 25.8% a year earlier.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1151271619?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-31 09:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1151271619","market":"nz","top_or_hot":-1,"title":"Stock Track | MODERN CHI MED Plummets 6.13% Intraday After Reporting FY2025 Loss and 32% Revenue Decline","media":"Stock Track","content":"<p>MODERN CHI MED's stock plummeted 6.13% during intraday trading on Tuesday.</p><p>The sharp decline followed the company's release of its full-year 2025 financial results, which showed a significant deterioration in performance. Modern Chinese Medicine Group swung to a net loss of RMB13.56 million for the year ended December 31, 2025, reversing a profit of RMB9.67 million in 2024.</p><p>Revenue fell 32.2% to RMB145.17 million, which management attributed to the loss of certain distributors, the removal of key products from China's national medical-insurance list, and price reductions under volume-based procurement reforms. The gross margin compressed to 16.2% from 25.8% a year earlier.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | MODERN CHI MED Plummets 6.13% Intraday After Reporting FY2025 Loss and 32% Revenue Decline</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | MODERN CHI MED Plummets 6.13% Intraday After Reporting FY2025 Loss and 32% Revenue Decline\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-31 09:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>MODERN CHI MED's stock plummeted 6.13% during intraday trading on Tuesday.</p><p>The sharp decline followed the company's release of its full-year 2025 financial results, which showed a significant deterioration in performance. Modern Chinese Medicine Group swung to a net loss of RMB13.56 million for the year ended December 31, 2025, reversing a profit of RMB9.67 million in 2024.</p><p>Revenue fell 32.2% to RMB145.17 million, which management attributed to the loss of certain distributors, the removal of key products from China's national medical-insurance list, and price reductions under volume-based procurement reforms. The gross margin compressed to 16.2% from 25.8% a year earlier.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01643","symbol_name":"现代中药集团","start_time":0,"source_url":"","article_id":"1151271619","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1151271619","pubTimestamp":1774920733,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"MODERN CHI MED's stock plummeted 6.13% during intraday trading on Tuesday.The sharp decline followed the company's release of its full-year 2025 financial results, which showed a significant...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01643":"现代中药集团"},"translate_title":"个股赛道|现代和黄医药盘中暴跌6.13%，此前公布2025财年亏损，营收下降32%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01643":1},"content_text":"MODERN CHI MED's stock plummeted 6.13% during intraday trading on Tuesday.The sharp decline followed the company's release of its full-year 2025 financial results, which showed a significant deterioration in performance. Modern Chinese Medicine Group swung to a net loss of RMB13.56 million for the year ended December 31, 2025, reversing a profit of RMB9.67 million in 2024.Revenue fell 32.2% to RMB145.17 million, which management attributed to the loss of certain distributors, the removal of key products from China's national medical-insurance list, and price reductions under volume-based procurement reforms. The gross margin compressed to 16.2% from 25.8% a year earlier.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1151271619","isCrawlerRequest":true}